Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline
Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.
BD Named One of America's Most Innovative Companies by Fortune
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of ...
BD Names Gregory J. Hayes to Board of Directors
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...
Becton, Dickinson and Company (NYSE:BDX) Rating Lowered to “Hold” at StockNews.com
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...
The Print1d
BD India Provides Knowledge-sharing Platform for Laboratory Personnel on Minimal Residual Disease
To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment ...
The Manila Times1d
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new ...
Le Lézard2d
Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management
The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by the pharmaceutical company Ferrer, gathered over 150 experts in pulmonology and ...
eLife5d
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.